Ulteriori capacità e competenze acquisite
Dal 10.2013 al 10.2017: Corso esecutore BLSD (Basic Life Support -Defibrillation)
Esperienza in Trial Clinici condotti secondo le regole della Good Clinical Practice (GCP):
•Sub-Investigator per il trial clinico protocollo n. DEB025A2312: “A Multicenter 3-Yer Follow-up Study to Asses the Durability of Sustained Virologic Response in Alispolivir-Treated Chronic Hepatitis C Patient”
•Sub-Investigator per il trial clinico protocollo n. MK3034-105- 00: “A Multicenter Single-Arm Study to Evaluate the Efficacy and Safety of Boceprevir 44 Weeks in Addition to Standard of Care (SOC) in Previously Treatment Failure (Relapser, NonResponder, both Partial and Null) Patient whit Chronic Hepatitis C Genotype 1 (G1) and Cirrhosis (F4 METAVIR)”
•Sub-Investigator per il trial clinico protocollo n. VX950HEP3002: “Multicenter, Open-Label, Early Access Program of Telaprevir in Combination with Peg-interferon Alfa and Ribavirin in Genotype 1 Chronic Hepatitis C Subjects with
Severe Fibrosis and Compensated Cirrhosis”
